Bouganin, an Attractive Weapon for Immunotoxins

Bougainvillea (Bougainvillea spectabilis Willd.) is a plant widely used in folk medicine and many extracts from different tissues of this plant have been employed against several pathologies. The observation that leaf extracts of Bougainvillea possess antiviral properties led to the purification and...

Full description

Bibliographic Details
Main Authors: Massimo Bortolotti, Andrea Bolognesi, Letizia Polito
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Toxins
Subjects:
Online Access:http://www.mdpi.com/2072-6651/10/8/323
_version_ 1811304460842958848
author Massimo Bortolotti
Andrea Bolognesi
Letizia Polito
author_facet Massimo Bortolotti
Andrea Bolognesi
Letizia Polito
author_sort Massimo Bortolotti
collection DOAJ
description Bougainvillea (Bougainvillea spectabilis Willd.) is a plant widely used in folk medicine and many extracts from different tissues of this plant have been employed against several pathologies. The observation that leaf extracts of Bougainvillea possess antiviral properties led to the purification and characterization of a protein, named bouganin, which exhibits typical characteristics of type 1 ribosome-inactivating proteins (RIPs). Beyond that, bouganin has some peculiarities, such as a higher activity on DNA with respect to ribosomal RNA, low systemic toxicity, and immunological properties quite different than other RIPs. The sequencing of bouganin and the knowledge of its three-dimensional structure allowed to obtain a not immunogenic mutant of bouganin. These features make bouganin a very attractive tool as a component of immunotoxins (ITs), chimeric proteins obtained by linking a toxin to a carrier molecule. Bouganin-containing ITs showed very promising results in the experimental treatment of both hematological and solid tumors, and one bouganin-containing IT has entered Phase I clinical trial. In this review, we summarize the milestones of the research on bouganin such as bouganin chemico-physical characteristics, the structural properties and de-immunization studies. In addition, the in vitro and in vivo results obtained with bouganin-containing ITs are summarized.
first_indexed 2024-04-13T08:07:36Z
format Article
id doaj.art-0972c408c6104ab2b44e3347b2c79983
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-13T08:07:36Z
publishDate 2018-08-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-0972c408c6104ab2b44e3347b2c799832022-12-22T02:55:06ZengMDPI AGToxins2072-66512018-08-0110832310.3390/toxins10080323toxins10080323Bouganin, an Attractive Weapon for ImmunotoxinsMassimo Bortolotti0Andrea Bolognesi1Letizia Polito2Department of Experimental, Diagnostic and Specialty Medicine-DIMES, General Pathology Section, Alma Mater Studiorum—University of Bologna, Via S. Giacomo 14, 40126 Bologna, ItalyDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, General Pathology Section, Alma Mater Studiorum—University of Bologna, Via S. Giacomo 14, 40126 Bologna, ItalyDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, General Pathology Section, Alma Mater Studiorum—University of Bologna, Via S. Giacomo 14, 40126 Bologna, ItalyBougainvillea (Bougainvillea spectabilis Willd.) is a plant widely used in folk medicine and many extracts from different tissues of this plant have been employed against several pathologies. The observation that leaf extracts of Bougainvillea possess antiviral properties led to the purification and characterization of a protein, named bouganin, which exhibits typical characteristics of type 1 ribosome-inactivating proteins (RIPs). Beyond that, bouganin has some peculiarities, such as a higher activity on DNA with respect to ribosomal RNA, low systemic toxicity, and immunological properties quite different than other RIPs. The sequencing of bouganin and the knowledge of its three-dimensional structure allowed to obtain a not immunogenic mutant of bouganin. These features make bouganin a very attractive tool as a component of immunotoxins (ITs), chimeric proteins obtained by linking a toxin to a carrier molecule. Bouganin-containing ITs showed very promising results in the experimental treatment of both hematological and solid tumors, and one bouganin-containing IT has entered Phase I clinical trial. In this review, we summarize the milestones of the research on bouganin such as bouganin chemico-physical characteristics, the structural properties and de-immunization studies. In addition, the in vitro and in vivo results obtained with bouganin-containing ITs are summarized.http://www.mdpi.com/2072-6651/10/8/323antiviral activityBougainvilleabouganincancer therapyimmunotherapyimmunotoxinsribosome-inactivating proteinsrRNA N-glycosylase activityVB6-845
spellingShingle Massimo Bortolotti
Andrea Bolognesi
Letizia Polito
Bouganin, an Attractive Weapon for Immunotoxins
Toxins
antiviral activity
Bougainvillea
bouganin
cancer therapy
immunotherapy
immunotoxins
ribosome-inactivating proteins
rRNA N-glycosylase activity
VB6-845
title Bouganin, an Attractive Weapon for Immunotoxins
title_full Bouganin, an Attractive Weapon for Immunotoxins
title_fullStr Bouganin, an Attractive Weapon for Immunotoxins
title_full_unstemmed Bouganin, an Attractive Weapon for Immunotoxins
title_short Bouganin, an Attractive Weapon for Immunotoxins
title_sort bouganin an attractive weapon for immunotoxins
topic antiviral activity
Bougainvillea
bouganin
cancer therapy
immunotherapy
immunotoxins
ribosome-inactivating proteins
rRNA N-glycosylase activity
VB6-845
url http://www.mdpi.com/2072-6651/10/8/323
work_keys_str_mv AT massimobortolotti bouganinanattractiveweaponforimmunotoxins
AT andreabolognesi bouganinanattractiveweaponforimmunotoxins
AT letiziapolito bouganinanattractiveweaponforimmunotoxins